Why does GLP-1 agonist combined with GIP and/or GCG agonist have greater weight loss effect than GLP-1 agonist alone in obese adults without type 2 diabetes?

已完结 10 由 Cassie 发布于 2025/4/10 12:33:45

DOI:10.1111/dom.16106
作者：Yuchen Jiang, Huijuan Zhu , Fengying Gong
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1111/dom.16106

Wiley

Abstract：Obesity is a chronic condition demanding effective treatment strategies, among which pharmacotherapy plays a critical role. As glucagon-like peptide-1 (GLP-1) agonist approved by the Food an

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Chemical Society (ACS)Superhydrophobic Tensile Designability of Silicone Rubber Composites.